Stay updated on KD025 Efficacy and Safety in cGVHD Clinical Trial
Sign up to get notified when there's something new on the KD025 Efficacy and Safety in cGVHD Clinical Trial page.

Latest updates to the KD025 Efficacy and Safety in cGVHD Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe page now shows a new revision tag: v3.5.4, replacing v3.5.3. This indicates a minor system or content update to the page rather than changes to the study data or eligibility.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page now shows Revision: v3.5.3, replacing the previous v3.5.2, indicating a backend or template update. This change does not alter the study text or data presented on the page.SummaryDifference0.0%

- Check37 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check52 days agoChange DetectedAdded the Blood 2021 ROCKstar Study citation; removed the Blood 2022 Erratum citation.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision updated to v3.5.0; previous revision v3.4.3 was removed.SummaryDifference0.0%

- Check73 days agoChange DetectedThe page now shows revision v3.4.3 and the previous revision v3.4.2 has been removed.SummaryDifference0.0%

Stay in the know with updates to KD025 Efficacy and Safety in cGVHD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KD025 Efficacy and Safety in cGVHD Clinical Trial page.